Case presentation
At admission, the patient showed obviously positive symptoms. She
urgently underwent a drug concentration test, and was considered “drug
intoxication”. She was given an emergency infusion to increase drug
excretion. The drug treatment of the patient was adjusted. After
pharmacogenomic examination, we found this patient was a
CYP1A2 ultra-rapid metabolizer.
At discharge, the clinical symptoms of the patient have decreased, and
her condition was stable.